NCT04971161: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb) |
|
|
| Recruiting | 2 | 200 | Europe | allo-APZ2-CVU, Skin-derived ABCB5-positive dermal mesenchymal stromal cells, Placebo | RHEACELL GmbH & Co. KG, FGK Clinical Research GmbH | Skin Ulcer Venous Stasis Chronic | 06/26 | 06/26 | | |